Drugs

$FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma – Genmab$

Jul 1, 2024, 06:09

FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma – Genmab

Genmab shared a post on LinkedIn:

“Breaking News:

The FDA has approved our medicine for the treatment of adults with relapsed/refractory follicular lymphoma who have received at least two prior therapies.

This approval marks the second FDA-approved indication for our therapy, developed in collaboration with AbbVie.”

$FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma - Genmab 1$

Source: Genmab/LinkedIn

AbbVie cancer cancer treatment FDA Genmab OncoDaily Oncology refractory follicular lymphoma

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Science

Feb 22, 2025, 15:33

Updated ESMO Clinical Practice Guideline on Hepatocellular Carcinoma

Science

Feb 22, 2025, 15:14

Erman Akkus: Stage specific characterization of early-onset colorectal cancer

Blog

Feb 22, 2025, 15:04

John Gordon: Successful CAR Tcell Therapy - "It's a Bug's Life"

Blog

Feb 22, 2025, 14:43

Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?

Science

Feb 22, 2025, 14:10

Yan Leyfman: Advancing CAR T-Cell Therapy - Off-the-Shelf Allogeneic Approach

Science

Feb 22, 2025, 13:28

Elvina Almuradova: Immunotherapy for HPV-Associated Cancers

Opinion

Feb 22, 2025, 13:10

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

Science

Feb 22, 2025, 13:10

Why immunotherapy has struggled in EGFR+ lung cancer - EGFR Positive Lung Cancer UK

Blog

Feb 22, 2025, 13:04

Debate session on the management of stage III NSCLC in the IO era - ESTRO

Celebrities

Feb 22, 2025, 11:40

Remembering Saxophonist James Casey: His Battle with Colon Cancer and Advocacy

Career

Feb 22, 2025, 11:36

Joseph H. Antin Received ASTCT Lifetime Achievement Award at 2025 Tandem Meetings

Science

Feb 22, 2025, 11:28

Myeloma Paper of the Day, February 22nd, suggested by Robert Orlowski